Pelvic FloorNCT04245137
Reference Intervals of the sEMG of the Pelvic Floor in Healthy Female
An observational study of Pelvic Floor, run by Peking Union Medical College Hospital at 7 sites in China.
Trial summary
This study is a multi-center survey of surface electromyography (sEMG) of pelvic floor muscles in healthy female. The aim of the study is to get the reference interval of normal pelvic floor sEMG from Chinese women. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pelvic Floor
- How many people
- 1,000 participants
- Where
- 7 sitesChina
- Study dates
- 1 Mar 2020to 31 Dec 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: healthy females with no symptoms of pelvic floor dysfunciton and normal contraciton strength, and at least 2 yrs postpartum.
Who may be able to join
- a. Having sex life and tolerable to vaginal examination b. There were no symptoms related to pelvic floor dysfunction; c. The modified Oxford grading system was 4 or 5; d. No birth or 2 years after the last delivery;
Who cannot join
- a. Duration of pregnancy and lactation; b. Within 2 years after delivery; c. Acute inflammation of vagina or discomfort of vagina; d. History of pelvic floor dysfunction: leakage of urine in the past 1 month when coughing / sneezing / lifting; leakage of urine in the past 1 month when urgency fecal incontinence in the past 1 month; usually have a bulge or something falling out that can be seen or felt in vaginal area; Pain in the abdomen or lumbosacral and buttocks below the navel for more than 6 months; e. History of radical pelvic surgery (cervical cancer, rectal cancer, bladder cancer, etc.); f. History of hysterectomy and subtotal hysterectomy; g. History of pelvic floor surgery (anti-incontinence and prolapse surgery); h. History of pelvic radiotherapy; i. Nervous system diseases that significantly affect muscle function; j. Those who can't cooperate with pelvic floor contraction
Trial locations and contacts
7 sites in 1 country.
7 sites in 1 country
China7 sites, 7 recruiting
- Recruiting
Peking Union Medical College Hospital, Chinese Academy of Medical Science
Beijing, Beijing Municipality, 100730
Juan Chen, 13521354364, pumchcj@sina.com
Lan Zhu
- Recruiting
Foshan Maternal and Child Health Care Hospital
Foshan, Guangdong, 528000
Zhengxian Xu
- Recruiting
Maternal and Child Health Hospital of Anhui Province
Hefei, Anhui, 230001
Hongmei Zhou, 1973517466@qq.com
- Recruiting
Gansu Province Maternal and Child Care Hospital
Lanzhou, Gansu, 730050
Min Zhou
- Recruiting
the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210029
Huan Ge, huange@njmu.edu.cn
Jie Wu
- Recruiting
Ningbo Women & Children's Hospital
Ningbo, Zhejiang, 315012
Bengui Jiang
- Recruiting
Xi'an' Fourth Hospital
Xi’an, Shanxi
Xinwen Zhang
About this study
Official title: A Cross-sectional Study of Female Pelvic Floor Surface Electromyography in Chinese Healthy Female
This study is a multi-center survey of surface electromyography (sEMG) of pelvic floor muscles in healthy female. The aim of the study is to get the reference interval of normal pelvic floor sEMG from Chinese women.
Read the detailed description
Pelvic floor dysfunction is a group of diseases caused by the damage of pelvic floor supporting structure. Pelvic floor muscles play an important role in the maintenance of pelvic floor function. Surface electromyography (sEMG) has been widely used to evaluate the function of pelvic floor muscles. The sEMG tests, which include pretest and posttest resting amplitude (µV), as well as phasic, tonic and endurance contractile amplitude (µV), are performed using Vishee neuro-muscle stimulator (MyoTrac Infiniti, model SA9800, Thought Technology Ltd., Montreal, Canada), following the Glazer protocols. A pear-shaped vaginal probe (serial number DYS180610, type VET-A, produced by Nanjing Vishee Medical Technology, Ltd.) is placed into the vagina when sEMG tests are performed. This is a cross-sectional survey. The reference intervals of pelvic floor sEMG in healthy female are evaluated.
- Conditions
- Pelvic Floor
What is being measured
The primary outcome is the main question the study is designed to answer.
resting amplitude (µV) pre baseline
pretest one minute rest
Measured: 1 day
Secondary outcomes (10)
coefficients of variability pre baseline
standard deviation divided by amplitudes at pretest resting period
Measured: 1 day
maximum rapid contraction amplitude (µV)
five rapid contractions (Flicks) with a 10 second rest before each one (phasic).
Measured: 1 day
recovery time at termination of rapid contraction(second)
recovery time until all muscles relax
Measured: 1 day
average amplitude of tonic contraction(µV)
five 10 second contractions with a 10 second rest before each one (tonic)
Measured: 1 day
coefficients of variability for the tonic contraction
standard deviation divided by amplitudes at tonic contraction period
Measured: 1 day
recovery time at termination of tonic contraction(second)
recovery time until all muscles relax
Measured: 1 day
average amplitude of endurance contraction(µV)
A 10 second rest followed by a single endurance contraction of 60 seconds (endurance)
Measured: 1 day
coefficients of variability for the endurance contraction
standard deviation divided by amplitudes at endurance contraction period
Measured: 1 day
resting amplitude (µV) post baseline
after-test one minute rest
Measured: 1 day
coefficients of variability post baseline
standard deviation divided by amplitudes at after-test resting period
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jan 2020
- Study start1 Mar 2020 (estimated)
- Primary completion31 Dec 2020 (estimated)
- Study completion31 Dec 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pelvic FloorStudies of the same condition, open and under way.
- More trials run by Peking Union Medical College HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Peking Union Medical College Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- The First Affiliated Hospital with Nanjing Medical University, Xi'an People's Hospital (Xi'an Fourth Hospital), Anhui Provincial Women and Children's Medical Center, Ningbo Women & Children's Hospital, Gansu Province Maternal and Child Care Hospital, Foshan Maternity and Child Health Care Hospital
- Responsible party
- Sponsor
- Investigators
- Lan Zhu, Principal investigator, zhu_julie@vip.sina.com
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04245137
- Sponsor's protocol ID
- sEMG-Normal
- Status last verified
- Jan 2020
- First submitted
- 26 Jan 2020
- Last updated
- 28 Jan 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Cross-sectional Study of Female Pelvic Floor Surface Electromyography in Chinese Healthy Female
- ClinicalTrials.gov ID
- NCT04245137
- Acronym / sponsor ID
- sEMG-Normal
- Conditions
- Pelvic Floor
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Peking Union Medical College HospitalUniversity, hospital or other
- Collaborators
- The First Affiliated Hospital with Nanjing Medical University, Xi'an People's Hospital (Xi'an Fourth Hospital), Anhui Provincial Women and Children's Medical Center, Ningbo Women & Children's Hospital, Gansu Province Maternal and Child Care Hospital, Foshan Maternity and Child Health Care Hospital
- Study start
- 1 Mar 2020 (estimated)
- Primary completion
- 31 Dec 2020 (estimated)
- Study completion
- 31 Dec 2020 (estimated)
- First posted
- 28 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is a multi-center survey of surface electromyography (sEMG) of pelvic floor muscles in healthy female. The aim of the study is to get the reference interval of normal pelvic floor sEMG from Chinese women.
Detailed description
Pelvic floor dysfunction is a group of diseases caused by the damage of pelvic floor supporting structure. Pelvic floor muscles play an important role in the maintenance of pelvic floor function. Surface electromyography (sEMG) has been widely used to evaluate the function of pelvic floor muscles. The sEMG tests, which include pretest and posttest resting amplitude (µV), as well as phasic, tonic and endurance contractile amplitude (µV), are performed using Vishee neuro-muscle stimulator (MyoTrac Infiniti, model SA9800, Thought Technology Ltd., Montreal, Canada), following the Glazer protocols. A pear-shaped vaginal probe (serial number DYS180610, type VET-A, produced by Nanjing Vishee Medical Technology, Ltd.) is placed into the vagina when sEMG tests are performed. This is a cross-sectional survey. The reference intervals of pelvic floor sEMG in healthy female are evaluated.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- healthy females with no symptoms of pelvic floor dysfunciton and normal contraciton strength, and at least 2 yrs postpartum.
Key inclusion criteria (1 listed)
- a. Having sex life and tolerable to vaginal examination b. There were no symptoms related to pelvic floor dysfunction; c. The modified Oxford grading system was 4 or 5; d. No birth or 2 years after the last delivery;
Key exclusion criteria (1 listed)
- a. Duration of pregnancy and lactation; b. Within 2 years after delivery; c. Acute inflammation of vagina or discomfort of vagina; d. History of pelvic floor dysfunction: leakage of urine in the past 1 month when coughing / sneezing / lifting; leakage of urine in the past 1 month when urgency fecal incontinence in the past 1 month; usually have a bulge or something falling out that can be seen or felt in vaginal area; Pain in the abdomen or lumbosacral and buttocks below the navel for more than 6 months; e. History of radical pelvic surgery (cervical cancer, rectal cancer, bladder cancer, etc.); f. History of hysterectomy and subtotal hysterectomy; g. History of pelvic floor surgery (anti-incontinence and prolapse surgery); h. History of pelvic radiotherapy; i. Nervous system diseases that significantly affect muscle function; j. Those who can't cooperate with pelvic floor contraction
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
resting amplitude (µV) pre baseline
Time frame: 1 day
pretest one minute rest
10 secondary outcomes
coefficients of variability pre baseline
Time frame: 1 day
maximum rapid contraction amplitude (µV)
Time frame: 1 day
recovery time at termination of rapid contraction(second)
Time frame: 1 day
average amplitude of tonic contraction(µV)
Time frame: 1 day
coefficients of variability for the tonic contraction
Time frame: 1 day
recovery time at termination of tonic contraction(second)
Time frame: 1 day
average amplitude of endurance contraction(µV)
Time frame: 1 day
coefficients of variability for the endurance contraction
Time frame: 1 day
resting amplitude (µV) post baseline
Time frame: 1 day
coefficients of variability post baseline
Time frame: 1 day
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2020.
- Individual participant dataSharing planned: No
Related trials for Pelvic Floor
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Not yet recruiting
Radiofrequency and Pelvic Floor Exercise for Primary Dysmenorrhea
Primary Dysmenorrhea
Recruiting
Effects of Pelvic Floor Muscle Training and a Modified Lumbopelvic Belt on Pain, Kinesiophobia, and Functional Status in Pregnant Women With Symphysis Pubis Pain
Symphysis Pubis Dysfunction, Pregnancy
Not yet recruitingObservational study
Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response
Urinary Incontinence (UI)
Not yet recruiting
Integrated Care Pathway for Hormonally Mediated Vestibulodynia: a Feasibility and Acceptability Pilot
Vestibulodynia, Vulvodynia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lan Zhu principal investigator
zhu_julie@vip.sina.com
7 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pelvic Floor, run by Peking Union Medical College Hospital at 7 sites in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 7 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Juan Chen (13521354364, pumchcj@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
resting amplitude (µV) pre baseline (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2020.